North america cancer monoclonal antibodies market report

1
RESEARCH REPORT JUN 2017
NORTH AMERICA CANCER MONOCLONAL ANTIBODIES MARKET
RESEARCH REPORT (2016-2021)
2
North America Cancer Monoclonal Antibodies Market
North America Cancer Monoclonal Antibodies Market
is estimated to be a USD 10.26 billion market in
2015 and is expected to reach USD 17 billion
market by the end of 2020 with a significant
growth rate of 10.5.
Cancer is the leading cause of death currently
across the globe. It starts with a single
cell genetically transforming normal cell into
tumour and is spread gradually to the other
cells. The dramatic increases in the number of
cancer cases has prompted many pharmaceutical
companies to invest in monoclonal antibodies. The
practise for curing cancer currently include
usage of drugs and chemotherapy which have
adverse side effects. This persuade the usage of
Monoclonal antibodies.
Recent years have seen the emergence of
monoclonal antibodies market, offering less
toxic and highly efficient therapeutics
alternatives. The antibody agents are used to
cure a wide array of diseases, especially cancer,
autoimmune and inflammatory diseases. They are
mono- specific antibodies having identical immune
cells that are clone to the single parent cells
and are directed to a specific target cell. This
customizable feature of the antibodies due to its
specific nature can play a critical role in
eliminating the cancer cell while sparing the
healthy cells. Monoclonal antibodies are more
effective in treating cancer than their counter
parts like drugs or chemotherapy owing to their
adverse side effects.
The drastic increase in the people affected by
cancer prompted many pharmaceutical firms
to invest in monoclonal antibodies. Rise in
investment in RD of genomic studies,
technological innovations in target gene
selection and genetic sequencing, monoclonal
antibodies ability to target only specific cells,
having no side effects compared to its counter
parts are the primary drivers for the market.
With the increased occurrence of cancer, the
market is expected to grow significantly in the
next 5 years having a presence of highly strong
products in the pipeline. There are also few
restraints for its market entry like high cost,
stringent guidelines, long durations required for
RD, clinical trials.
The North America Monoclonal Antibodies are
categorised on the basis of application
as Breast, Brain, blood, Liver, Hodgkins and
Non-Hodgkins lymphoma, leukaemia, colorectal and
others. The market is again segmented based on
type as chimeric and humanised antibodies, murine
antibodies and fully humanized antibodies. The
market is again divided into various categories
by conjugated cancer therapies as
Radoimmunotherapy, ADEPT, Immunoliposome,
immunocytokines and others. Based on the
geographical region of North America it is
segmented into US and Canada.
The major companies in this industry are Amgen,
Genmab, Briston Myers squibb, glaxosmithkline,
Eli Lilly, Roche, Immunogen, Seattle Genetics,
Novartis and Spectrum Pharmaceuticals.
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
3
North America Cancer Monoclonal Antibodies Market
TABLE OF CONTENTS
1.
Introduction
1.1 Market Definition 1.2 Study Deliverables 1.3
Base Currency, Base Year and Forecast Periods 1.4
General Study Assumptions
2.
Research Methodology
2.1 Introduction 2.2 Research Phases 2.2.1
Secondary Research 2.2.2 Primary Research 2.2.3
Econometric Modelling 2.2.4 Expert Validation 2.3
Analysis Design 2.4 Study Timeline
3.
Overview
3.1 Executive Summary 3.2 Key Inferences 3.3 New
Developments
4.
Drivers, Restraints, Opportunities, and
Challenges Analysis (DROC)
4.1 Market Drivers 4.2 Market Restraints 4.3 Key
Challenges 4.4 Current Opportunities in the Market
5.
Market Segmentation
5.1 By Application 5.1.1 Liver 5.1.2 Breast 5.1.3
Brain
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
4
North America Cancer Monoclonal Antibodies Market
5.1.4 Blood 5.1.5 Hodgkins and Non-Hodgkins
lymphoma 5.1.6 Colorectal 5.1.7 Leukaemia 5.1.8
Others
View Full Report _at_ http//www.marketdataforecast.c
om/market-reports/north-america- cancer-monoclonal
-antibodies-market-187/
5.2 By Type 5.2.1 Murine Antibodies 5.2.2
Chimeric and Humanised Antibodies 5.2.3 Fully
Humanized Antibodies 5.3 Conjugate Cancer
Therapies 5.3.1 Immunoliposome 5.3.2
Radioimmunotherapy 5.3.3 ADEPT 5.3.4
Immunocytokines 5.3.5 Others
Download Free Sample Report _at_ http//www.marketda
taforecast.com/market-reports/north- america-cance
r-monoclonal-antibodies-market-187/request-sample
6. Geographical Analysis
6.1 Introduction 6.2 United States 6.3 Canada
Inquire before buying _at_ http//www.marketdatafore
cast.com/market-reports/north-america- cancer-mono
clonal-antibodies-market-187/inquire
7. Strategic Analysis
7.1 PESTLE analysis 7.1.1 Political 7.1.2
Economic 7.1.3 Social 7.1.4 Technological
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
5
North America Cancer Monoclonal Antibodies Market
7.1.5 Legal 7.1.6 Environmental 7.2 Porters Five
analysis 7.2.1 Bargaining Power of
Suppliers 7.2.2 Bargaining Power of
Consumers 7.2.3 Threat of New Entrants 7.2.4
Threat of Substitute Products and Services 7.2.5
Competitive Rivalry within the Industry
Buy now Report _at_ http//www.marketdataforecast.com
/cart/buy-now/north-america-cancer- monoclonal-ant
ibodies-market-187
8.
Market Leaders' Analysis
8.1 Roche 8.1.1 Overview 8.1.2 Product
Analysis 8.1.3 Strategic Evaluation and
Operations 8.1.4 Financial analysis 8.1.5 Legal
issues 8.1.6 Recent Developments 8.1.7 SWOT
analysis 8.1.8 Analyst View 8.2 Amgen 8.3
Genmab 8.4 Glaxosmithkline 8.5 Bristol Meyer
Squibb 8.6 Eli Lilly 8.7 Immunogen 8.8
Novartis 8.9 Seattle Genetics 8.10 Spectrum
Pharmaceuticals
9.
Competitive Landscape
9.1 Market share analysis 9.2 Merger and
Acquisition Analysis
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
6
North America Cancer Monoclonal Antibodies Market
9.3 Agreements, collaborations and Joint
Ventures 9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook 10.2 Investment Opportunities
Appendix
1. 2.
List of Tables List of Figures
Checkout other related studies in the Healthcare
Segment Reports
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
7
North America Cancer Monoclonal Antibodies Market
?
Optogenetics Market http//www.marketdataforecas
t.com/market- reports/global-optogenetics-market-1
219/
? ?
Portable Ultrasound Market http//www.marketdataf
orecast.com/market-reports/global-portable-
ultrasound-market-647/
? ?
In-Vitro Toxicology Testing Market http//www.mar
ketdataforecast.com/market-reports/global-in-vitro
- toxicology-testing-market-184/
? ?
Pyrogen Testing Market http//www.marketdataforec
ast.com/market-reports/global-pyrogen-
testing-market-431/
?
Companion Animal Health Care Market http//www.ma
rketdataforecast.com/market-reports/global-compani
on- animal-health-care-market-1249/
?
Veterinary Vaccines Market http//www.marketdata
forecast.com/market- reports/veterinary-vaccines-m
arket-75/
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
8
North America Cancer Monoclonal Antibodies Market
SCOPE OF THE REPORT
?
Regional and country-level analysis and forecasts
of the study market providing Insights on the
major countries/regions in which this industry is
blooming and to also identify the regions that
are still untapped Segment-level analysis in
terms of technology, component, and type along
with market size forecasts and estimations to
detect key areas of industry growth in detail
Identification of key drivers, restraints,
opportunities, and challenges (DROC) in the
market and their impact on shifting market
dynamics Study of the effect of exogenous and
endogenous factors that affect the global
market which includes broadly demographic,
economics, and political, among other
macro-environmental factors presented in an
extensive PESTLE Analysis Study the micro
environment factors that determine the overall
profitability of an Industry, using Porters
five forces analysis for analyzing the level of
competition and business strategy development A
comprehensive list of key market players
along with their product portfolio, current
strategic interests, key financial information,
legal issues, SWOT analysis and analyst overview
to study and sustain the market
environment Competitive landscape analysis
listing out the mergers, acquisitions,
collaborations in the field along with new
product launches, comparative financial studies
and recent developments in the market by the
major companies An executive summary, abridging
the entire report in such a way that decision-
making personnel can rapidly become acquainted
with background information, concise analysis
and main conclusions Expertly devised analyst
overview along with Investment opportunities to
provide both individuals and organizations a
strong financial foothold in the market
?
?
?
?
?
?
?
?
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com
9
ABOUT US Market Data Forecast is a firm working
in the areas of market research and business
intelligence. We have rich experience in
research across various business domains and we
cater to the needs of both individual and
corporate clients. Our research services assist
clients in key business areas like business
process improvement, key decision making and
developing appropriate corporate strategy. We
are truly committed to our clients and
other stakeholders for providing customized
research services of the highest quality.
CONTACT INFORMATION We always look forward to
working with new clients, pushing our
boundaries and extending our reach beyond
global touch with us for further queries.
horizons.
Get in
Website www.marketdataforecast.com
E-Mail contact_at_marketdataforecast.com
Phone [phone] (U.S Toll free),
91 7680952236 (Indian Office).
FOR MORE INFORMATION
1 888-702-9626 www.marketdataforecast.com
contact_at_marketdataforecast.com